Treatment Recommendations Following 3-Day Masked Continuous Glucose Monitoring (CGM) in Youth With Type 1 Diabetes
Authors:
Open Access
- 22 March 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 8 (3) , 494-497
Abstract
Glycemic control remains suboptimal in youth with type 1 diabetes. Retrospective continuous glucose monitoring (CGM) has demonstrated utility in fine-tuning diabetes management by detecting postprandial hyperglycemia and hypoglycemia. In this study, we explored the process of 3-day masked CGM use, subsequent treatment recommendations, and impact on A1c in a clinic-based sample of youth with type 1 diabetes. Over 2 years, 122 youth were referred for masked CGM. Patients/families completed a diary of blood glucose levels, insulin doses, food intake, and exercise during CGM use. A1c was assessed pre- and 2-3 months post-CGM. Treatment recommendations were formulated using data from CGM reports and diaries. Mean age was 14.3 ± 3.9 years, diabetes duration was 7.5 ± 4.7 years, and A1c was 8.5 ± 1.1% (69 ± 12 mmol/mol); 61% were pump-treated. Patients received an average of 3.1 ± 1.1 treatment recommendations following review of the CGM report. Most (80%) received reinforcement of the importance of preprandial bolusing; 37% received a recommendation regarding advanced insulin management (use of combination boluses/attend to active insulin). Receipt of the latter recommendation was related to A1c improvement ≥0.5% (OR: 4.0, P < .001). Masked CGM offers opportunities to guide advanced insulin management (by injection or pump), which may yield A1c improvements in youth with type 1 diabetes.Keywords
This publication has 12 references indexed in Scilit:
- Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical GuidelinesDiabetes Care, 2013
- Clinical Outcomes Associated with Referral-Based Continuous Glucose Monitoring Using a Central Standardized Interpretation StrategyDiabetes Technology & Therapeutics, 2012
- Effect of Short-Term iPRO Continuous Glucose Monitoring on Hemoglobin A1c Levels in Clinical PracticeDiabetes Technology & Therapeutics, 2012
- Outpatient Assessment of Determinants of Glucose Excursions in Adolescents with Type 1 Diabetes: Proof of ConceptDiabetes Technology & Therapeutics, 2012
- Continuous Glucose Monitoring in Youth with Type 1 Diabetes: 12-Month Follow-Up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized TrialDiabetes Technology & Therapeutics, 2010
- Effect of Puberty on the Pharmacodynamic and Pharmacokinetic Properties of Insulin Pump Therapy in Youth With Type 1 DiabetesDiabetes Care, 2008
- Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome?Diabetes Care, 2007
- Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose MonitoringDiabetes Care, 2006
- The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic riskDiabetes/Metabolism Research and Reviews, 2002
- Limitations of Conventional Methods of Self-Monitoring of Blood GlucoseDiabetes Care, 2001